Among the 37 squamous cell carcinoma NSCLC patients, 19 patients underwent genetic testing and 1 patient (2.7%) harboured EGFR exon 19 deletion mutation and 1 (2.7%) patient harboured KRAS-L19F mutation. Here, KRAS is linked to squamous cell carcinoma.